Superiority of prolonged low-dose azanucleoside administration? : Results of 5-aza-2′-deoxycytidine retreatment in high-risk myelodysplasia patients
Björn Rüter, Pierre W. Wijermans, Michael LübbertVolume:
106
Year:
2006
Language:
english
Pages:
7
DOI:
10.1002/cncr.21796
File:
PDF, 115 KB
english, 2006